Utilizing the Crosstalk Among Chicoric Acid, 13-Cis Retinoic Acid(Aerosolized), Minocycline and Vitamin D as a Potent Quadrate Therapy for Treating Patients With Multidrug-resistant TB and Patient With Both Multidrug-resistant TB and COVID-19
Clinical trial NCT05077813 · UNKNOWN
Trial details
- NCT number
- NCT05077813
- Sponsor
- Kafrelsheikh University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-01
- Primary completion
- 2022-02-01
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.